These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34909060)

  • 1. Scoping insight on antiviral drugs against COVID-19.
    Ali AS; Ibrahim IM; Burzangi AS; Ghoneim RH; Aljohani HS; Alsamhan HA; Barakat J
    Arab J Chem; 2021 Oct; 14(10):103385. PubMed ID: 34909060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of Remdesivir, Lopinavir/Ritonavir, and Favipiravir for COVID-19 Treatment: A Systematic Review.
    Qomara WF; Primanissa DN; Amalia SH; Purwadi FV; Zakiyah N
    Int J Gen Med; 2021; 14():8557-8571. PubMed ID: 34849001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological Strategies for COVID-19 - A Review of the Most Promising Repurposed Antiviral Drugs.
    Chopra D; Boparai JK; Bhandari B; Srivastava A; Gupta R
    Infect Disord Drug Targets; 2021; 21(7):e160921189260. PubMed ID: 33342420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Narrative Review of Antiviral Drugs Used for COVID-19 Pharmacotherapy.
    Kumar S; Saurabh MK; Maharshi V; Saikia D
    J Pharm Bioallied Sci; 2021; 13(2):163-171. PubMed ID: 34349475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of antiviral combination therapy in symptomatic patients of Covid-19 infection - a randomised controlled trial (SEV-COVID Trial): A structured summary of a study protocol for a randomized controlled trial.
    Panda PK; Bandyopadhyay A; Singh BC; Moirangthem B; Chikara G; Saha S; Bahurupi YA
    Trials; 2020 Oct; 21(1):866. PubMed ID: 33081849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic Effectiveness and Safety of Repurposing Drugs for the Treatment of COVID-19: Position Standing in 2021.
    Alam S; Kamal TB; Sarker MMR; Zhou JR; Rahman SMA; Mohamed IN
    Front Pharmacol; 2021; 12():659577. PubMed ID: 34220503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Update on Antiviral Therapy Against SARS-CoV-2: How Far Have We Come?
    Indari O; Jakhmola S; Manivannan E; Jha HC
    Front Pharmacol; 2021; 12():632677. PubMed ID: 33762954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Trials of Repurposed Antivirals for SARS-CoV-2.
    Martinez MA
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32631826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic and Statistical Review of Coronavirus Disease 19 Treatment Trials.
    Siordia JA; Bernaba M; Yoshino K; Ulhaque A; Kumar S; Bernaba M; Bergin E
    SN Compr Clin Med; 2020; 2(8):1120-1131. PubMed ID: 32838169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drugs intervention study in COVID-19 management.
    Taher M; Tik N; Susanti D
    Drug Metab Pers Ther; 2021 Apr; ():. PubMed ID: 33818031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the efficacy and safety of favipiravir and interferon compared to lopinavir/ritonavir and interferon in moderately ill patients with COVID-19: a structured summary of a study protocol for a randomized controlled trial.
    Hassaniazad M; Bazram A; Hassanipour S; Fathalipour M
    Trials; 2020 Oct; 21(1):886. PubMed ID: 33109246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Mechanism of Action of Repurposed Drugs and Traditional Chinese Medicine Used for the Treatment of Patients Infected With COVID-19: A Systematic Scoping Review.
    Lem FF; Opook F; Lee DJH; Chee FT; Lawson FP; Chin SN
    Front Pharmacol; 2020; 11():585331. PubMed ID: 33746739
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical Management of COVID-19: A Review of Pharmacological Treatment Options.
    Heustess AM; Allard MA; Thompson DK; Fasinu PS
    Pharmaceuticals (Basel); 2021 May; 14(6):. PubMed ID: 34071185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of lopinavir/ritonavir and hydroxychloroquine against severe acute respiratory syndrome coronavirus 2 at concentrations achievable by usual doses.
    Kang CK; Seong MW; Choi SJ; Kim TS; Choe PG; Song SH; Kim NJ; Park WB; Oh MD
    Korean J Intern Med; 2020 Jul; 35(4):782-787. PubMed ID: 32460458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral treatment selection for SARS-CoV-2 pneumonia.
    Bassetti M; Corcione S; Dettori S; Lombardi A; Lupia T; Vena A; De Rosa FG; Gori A; Giacobbe DR
    Expert Rev Respir Med; 2021 Aug; 15(8):985-992. PubMed ID: 33962524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacotherapy in COVID-19; A narrative review for emergency providers.
    Mehta N; Mazer-Amirshahi M; Alkindi N; Pourmand A
    Am J Emerg Med; 2020 Jul; 38(7):1488-1493. PubMed ID: 32336586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TAT-peptide conjugated repurposing drug against SARS-CoV-2 main protease (3CLpro): Potential therapeutic intervention to combat COVID-19.
    Ansari MA; Jamal QMS; Rehman S; Almatroudi A; Alzohairy MA; Alomary MN; Tripathi T; Alharbi AH; Adil SF; Khan M; Shaheer Malik M
    Arab J Chem; 2020 Nov; 13(11):8069-8079. PubMed ID: 34909057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Pharmacokinetic and Pharmacodynamic Properties of Hydroxychloroquine and Dose Selection for COVID-19: Putting the Cart Before the Horse.
    Morrisette T; Lodise TP; Scheetz MH; Goswami S; Pogue JM; Rybak MJ
    Infect Dis Ther; 2020 Sep; 9(3):561-572. PubMed ID: 32740858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Update on Current Therapeutic Drugs Treating COVID-19.
    Wu R; Wang L; Kuo HD; Shannar A; Peter R; Chou PJ; Li S; Hudlikar R; Liu X; Liu Z; Poiani GJ; Amorosa L; Brunetti L; Kong AN
    Curr Pharmacol Rep; 2020; 6(3):56-70. PubMed ID: 32395418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics under the COVID-19 storm.
    Pilla Reddy V; El-Khateeb E; Jo H; Giovino N; Lythgoe E; Sharma S; Tang W; Jamei M; Rastomi-Hodjegan A
    Br J Clin Pharmacol; 2023 Jan; 89(1):158-186. PubMed ID: 33226664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.